… -2 oral drugs (nirmatrelvir/ritonavir and molnupiravir), (iii) summarizes the clinical progress of
other oral antivirals for use in COVID-19, (iv… with the use of oral antivirals in clinical practice. …

… distributed oral antivirals are urgently needed to treat coronavirus disease-2019 (COVID-19), …
, and block transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

… made in COVID-19 research and many antiviral drugs have … against COVID-19, a simple
oral antiviral drug for COVID-19 has … among COVID-19 patients with three new oral antivirals (…

… This review aims to summarize ongoing antiviral treatments in COVID-19, to discuss …
COVID-19) evaluating oral antiviral Favipiravir's at home use for mild-to-moderate COVID-19 …

… “The oral antivirals do not have the complications of the … be the most widely available antiviral
for COVID-19. Paxlovid is a … order of 50 000 doses of the antiviral—the interim results had …

… -based antiviral agents could be repurposed for COVID-19 treatment. … COVID-19 epidemic
and is potentially to be used to treat future coronavirus infections as well as other coronavirus-…

… 2 COVID-19 oral antivirals amid the peak of an outbreak with omicron variant infections in a
densely populated city. Compared with no antiviral … patients with COVID-19. Neither of the …

… New treatments are needed to reduce the risk of progression of coronavirus disease 2019
(Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against …

… —the development of oral antiviral treatment for COVID-19 still needs further study. In addition
to molnupiravir, four more oral anti-COVID-19 drugs are in phase 3 clinical trials: the 3CL …

… Despite this breakthrough, COVID-19 will constitute an enduring public health issue [8]. …
oral alternatives [15]. In early 2021, EMA approved the first oral antiviral against COVID-19, ie, …